The design of sensors to monitor the activity state of specific protein kinases is challenging due to the complexity of eukaryotic kinomes. Here we describe a peptide-based photaffinity probe that specifically labels the active conformation of the Abl tyrosine kinase.
Protein kinases are key players in intracellular signaling pathways that control all aspects of cell behavior. Because protein kinases often promote cell survival and growth, aberrant kinase activity frequently contributes to cancer, and kinase inhibitors have become important anti-cancer drugs. [1] Accordingly, much effort has been expended towards the design of protein or peptide-based reporters to probe the activity of specific protein kinases in complex systems (cell lysates, intact cells, tissues or tumors). [2] However, these approaches require that the substrate must be exquisitely specific for the kinase of interest, a major challenge given that there are over 500 human protein kinases that could potentially provide "off-target" activity. [3] An alternative to the use of substrates to profile enzyme activity in crude systems is to use affinity probes that bind to the enzyme in an activitydependent manner. Because such activity-based probes (ABPs) covalently label their targets, binding to multiple enzymes is actually advantageous, as it can facilitate profiling of entire classes of molecules. ABPs have been developed and applied most extensively for hydrolytic enzymes, including lipid esterases, proteases, and phosphatases, [4] but have been lacking for protein kinases. We describe here a photoaffinity probe based on a consensus peptide substrate that specifically labels the active conformation of the oncogenic protein tyrosine kinase Abl. In some contexts this probe behaves like an ABP, reporting on the activation state of the kinase. Our approach should allow for the general design of conformation-specific probes for many protein kinases.
A nearly universal feature of kinase activation involves conformational reorganization of a region adjacent to the catalytic cleft called the activation loop. [5] The activation loop constitutes a portion of the protein substrate binding site, suggesting that probes based on a peptide substrate are likely to be specific for the active conformation. To test this hypothesis, we generated a probe targeting the non-receptor tyrosine kinase Abl (Scheme 1), an established oncology target deregulated in chronic myelogenous leukemia through a gene rearrangement leading to a constitutively active fusion protein (BCR-Abl). We based our probe on a consensus substrate (ABLtide, Figure 1 ) generated through peptide library screening. [6] ABPs typically consist of a reactive group that targets the enzyme linked to a reporter, either a fluorescent tag or affinity handle. [7] To allow covalent targeting of the kinase, we incorporated a photocrosslinking phenyl azide group (4-azidophenylalaine, Z) into the peptide sequence. We chose to insert the Z residue at the P+2 position (two residues downstream of the phosphorylation site), as X-ray crystal structures of Abl-peptide complexes [8] suggested that substitution at that position would not affect peptide binding. To facilitate detection, we incorporated a biotin moiety at the C-terminus to generate the probe (ABL-Z, Figure 1 ).
Incubation of purified recombinant Abl with ABL-Z followed by UV irradiation resulted in covalent incorporation of biotin into the kinase as judged by detection with streptavidinhorseradish peroxidase (HRP) following SDS-PAGE and transfer to a membrane ( Figure 1 ). Labeling was UV-dependent, and could be competed with increasing concentrations of unlabeled peptide but not a scrambled peptide control. When labeling was carried out in the presence of equal amounts of another tyrosine kinase, Src, label was incorporated predominantly into Abl and to a lesser degree into the off-target kinase. These results suggest that ABL-Z crosslinks to Abl specifically through binding to the active site cleft. UV-dependent labeling of Abl also occurred in a crude cell lysate ( Figure S1 ). In this context detection of label incorporation was accomplished by immunoblotting for the presence of Abl among proteins isolated using avidin resin. Biotin affinity isolation was necessary due to a high degree of labeling of other proteins, presumably due to excess label in free solution reacting through random collision. However, in crude lysates we could detect Abl with high sensitivity (<24 fmol kinase).
To establish whether ABL-Z could be used in a manner similar to an ABP, we first performed experiments with recombinant Abl in which we manipulated its activation state. Abl purified from mammalian cells exhibited a basal level of activity as detected by ABLtide phosphorylation (Figure 2 ). Abl activity is enhanced by phosphorylation at multiple sites within the kinase, [9] and lambda phosphatase (λPP) treatment reduces its activity. We also generated a triple point mutant (G2A/P242E/P249E, or GPP) that disrupts intramolecular interactions that restrain Abl kinase activity, [10] resulting in constitutively higher activity than wild-type (WT) Abl. These three forms of Abl were subjected to labeling with ABL-Z. The extent of labeling increased with increasing catalytic activity, indicating that in this context ABL-Z behaves as expected for an ABP (Figure 2 ).
As another means to assess the specificity of our probe for the active form of Abl, we used two clinical inhibitors known to bind specific conformations of the kinase. STI-571 (imatinib/Gleevec) induces an inactive conformation of Abl in which the active site cleft is occluded through an intramolecular pseudosubstrate interaction. [11] In contrast, the dual Src/ Abl inhibitor dasatinib binds to the active conformation of Abl. [12] In these experiments WT or mutant Abl was expressed in mammalian cells and labeling was performed in crude cell lysates. As anticipated, STI-571 almost completely blocked labeling by ABL-Z, while dasatinib actually increased the extent of labeling (Figure 3) . We confirmed that both compound inhibited Abl when purified from the same cell lysates ( Figure S2 ). These results provide further evidence that ABL-Z specifically targets the active conformation of Abl.
These results illustrate the use of peptide substrate-based probes to assess the activity state of protein kinases in crude systems. Protein kinase affinity labels have previously been generated by derivatizing ATP or ATP-competitive small molecule inhibitors. [13] In addition, affinity resins consisting of immobilized inhibitors have been used to profile kinase expression in cell lysates. [14] These approaches have been valuable for profiling kinase expression and for assessing inhibitor selectivity and potency in situ. However, because ATP or inhibitor affinity need not correlate with the activity state of a kinase, these probes are not necessarily suitable for activity-based profiling. In contrast, because kinase activation can involve rearrangement of the peptide binding site, peptide substrate-based probes should frequently bind in an activity-dependent manner.
While the current probe was designed to target Abl, alterations in the peptide sequence should enable tuning the reactivity of such probes to target essentially any kinase of interest. It is unlikely that a short peptide sequence will be absolutely specific for a single kinase. However, cross-reactivity with other kinases does not limit use of such probes, since specific targets of interest can be detected by immunoblotting or by mass spectrometry following affinity isolation of bound proteins. In this way a limited number of probes can potentially be used to detect activity of a large number of kinases. While detection of endogenous kinase using the current probe is hampered by low affinity for Abl leading to low crosslinking efficiency (<1.3%), increasing peptide affinity through screening of peptide libraries [15] or the use of bivalent inhibitors [16] should allow detection of endogenous kinases in an activity-dependent manner. In addition, appending cell penetrating peptide sequences would allow their use in intact cells. In this way peptide substrate based probes should allow one to establish the repertoire of active kinases present in a cell line or tumor, and may thereby suggest new therapeutic targets.
Experimental Section
Experimental details are provided in the Supporting Information.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Labeling of Abl in the presence of inhibitors that bind to distinct conformations of the kinase. Crude lysates of HEK293T cells expressing WT or mutant Abl were treated with 5 μM ABL-Z in the presence of the indicated concentrations of inhibitor prior to irradiation and analysis of probe crosslinking.
Scheme 1.
Labeling and detection of the Abl tyrosine kinase. The active conformation of Abl with an intact peptide substrate binding site can be induced either by phosphorylation of the kinase or by binding of specific inhibitors such as dasatinib. Conversely, dephosphorylation of Abl or binding of the inhibitor STI571 induces an inactive conformation that is incapable of binding peptide substrates. A biotin-conjugated peptide photoaffinity label binds to the substrate-binding cleft of Abl in its active conformation. Irradiation of the complex triggers photocrosslinking, and the extent of probe incorporation correlates with the activity state of the kinase.
